A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial-Reference-Cited by-同舟云学术

A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

Published:2021-03 Issue:3 Volume:147 Page:1020-1030.e10
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Demoly Pascal,Corren Jonathan,Creticos Peter,De Blay Frédéric,Gevaert Philippe,Hellings Peter,Kowal Krzysztof,Le Gall Martine,Nenasheva Natalia,Passalacqua Giovanni,Pfaar Oliver,Tortajada-Girbés Miguel,Vidal Carmen,Worm Margitta,Casale Thomas B.

Funder

Stallergenes Greer

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference55 articles.

1. Distribution and determinants of house dust mite allergens in Europe: the European Community Respiratory Health Survey II;Zock;J Allergy Clin Immunol,2006

2. Geography of house dust mite allergens;Thomas;Asian Pac J Allergy Immunol,2010

3. House dust mite allergens in asthma and allergy;Thomas;Trends Mol Med,2010

4. Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys;Meltzer;Allergy Asthma Proc,2012

5. The burden of allergic rhinitis and asthma;Ozdoganoglu;Ther Adv Respir Dis,2012

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focused allergic rhinitis practice parameter for Canada;Allergy, Asthma & Clinical Immunology;2024-08-08

2. Sublingual allergen immunotherapy prevents house dust mite inhalant type 2 immunity through dendritic cell-mediated induction of Foxp3+ regulatory T cells;Mucosal Immunology;2024-08

3. The evidence for commercial house dust mite immunotherapy products: A pragmatic systematic review with narrative synthesis;Journal of Allergy and Clinical Immunology: Global;2024-08

4. Blood and local eosinophil levels in chronic rhinitis: Observations during seasonal allergen exposure and non-exposure;World Allergy Organization Journal;2024-07

5. Consistent efficacy and safety of sublingual immunotherapy tablets across allergens and geographic regions;Allergy and Asthma Proceedings;2024-07-01